PT - JOURNAL ARTICLE AU - Natarajan, Aravind AU - Han, Alvin AU - Zlitni, Soumaya AU - Brooks, Erin F. AU - Vance, Summer E. AU - Wolfe, Marlene AU - Singh, Upinder AU - Jagannathan, Prasanna AU - Pinsky, Benjamin A. AU - Boehm, Alexandria AU - Bhatt, Ami S. TI - Standardized and optimized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA AID - 10.1101/2021.04.10.21255250 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.10.21255250 4099 - http://medrxiv.org/content/early/2021/04/17/2021.04.10.21255250.short 4100 - http://medrxiv.org/content/early/2021/04/17/2021.04.10.21255250.full AB - COVID-19 patients shed SARS-CoV-2 viral RNA in their stool, sometimes well after they have cleared their respiratory infection. This feature of the disease may be significant for patient health, epidemiology, and diagnosis. However, to date, methods to preserve stool samples from COVID patients, and to extract and quantify viral RNA concentration have yet to be optimized. We sought to meet this urgent need by developing and benchmarking a standardized protocol for the fecal detection of SARS-CoV-2 RNA. We test three preservative conditions for their ability to yield detectable SARS-CoV-2 RNA: OMNIgene-GUT, Zymo DNA/RNA shield kit, and the most common condition, storage without any preservative. We test these in combination with three extraction kits: the QIAamp Viral RNA Mini Kit, Zymo Quick-RNA Viral Kit, and MagMAX Viral/Pathogen Kit. Finally, we also test the utility of two detection methods, ddPCR and RT-qPCR, for the robust quantification of SARS-CoV-2 viral RNA from stool. We identify that the Zymo DNA/RNA shield collection kit and the QiaAMP viral RNA mini kit yield more detectable RNA than the others, using both ddPCR and RT-qPCR assays. We also demonstrate key features of experimental design including the incorporation of appropriate controls and data analysis, and apply these techniques to effectively extract viral RNA from fecal samples acquired from COVID-19 outpatients enrolled in a clinical trial. Finally, we recommend a comprehensive methodology for future preservation, extraction and detection of RNA from SARS-CoV-2 and other coronaviruses in stool.Competing Interest StatementA.N., A.H., S.Z., E.F.B., S.E.V., M.W., A.Bo., and A.S.B. are co-inventors on a U.S. provisional patent application #63/172,045 that has been filed and relates to the methods presented in this manuscript.Funding StatementNo authors received payment or services from a third party for any aspect of this submitted work. This work was funded by Institutional funds from Stanford University as well as NIH grants that support the Bhatt lab. One of the investigators was also supported by an NSF Graduate Research Fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Stanford University IRB approved this work, as indicated in the main text of the manuscript.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data included in this manuscript are available as supplementary data tables within this submission.